These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25808574)

  • 1. Serum heparanase levels: A protective marker against digital ulcers in patients with systemic sclerosis.
    Wu CY; Asano Y; Taniguchi T; Sato S; Yu HS
    J Dermatol; 2015 Jun; 42(6):625-8. PubMed ID: 25808574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum omentin levels: A possible contribution to vascular involvement in patients with systemic sclerosis.
    Miura S; Asano Y; Saigusa R; Yamashita T; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Tamaki Z; Tada Y; Sugaya M; Sato S; Kadono T
    J Dermatol; 2015 May; 42(5):461-6. PubMed ID: 25766303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of serum soluble Tie1 levels in patients with systemic sclerosis.
    Noda S; Asano Y; Aozasa N; Akamata K; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S
    Arch Dermatol Res; 2013 May; 305(4):325-31. PubMed ID: 23233281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenic and angiostatic factors in renal scleroderma-associated vasculopathy.
    Gigante A; Navarini L; Margiotta D; Amoroso A; Barbano B; Cianci R; Afeltra A; Rosato E
    Microvasc Res; 2017 Nov; 114():41-45. PubMed ID: 28602918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of organ involvement in systemic sclerosis by serum biomarkers and peripheral endothelial function.
    Kawashiri SY; Nishino A; Igawa T; Takatani A; Shimizu T; Umeda M; Fukui S; Okada A; Suzuki T; Koga T; Iwamoto N; Ichinose K; Tamai M; Nakashima M; Mizokami A; Matsuoka N; Migita K; Ogawa F; Ikeda S; Maemura K; Nakamura H; Origuchi T; Maeda T; Kawakami A
    Clin Exp Rheumatol; 2018; 36 Suppl 113(4):102-108. PubMed ID: 29652651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenic biomarkers predict the occurrence of digital ulcers in systemic sclerosis.
    Avouac J; Meune C; Ruiz B; Couraud PO; Uzan G; Boileau C; Kahan A; Chiocchia G; Allanore Y
    Ann Rheum Dis; 2012 Mar; 71(3):394-9. PubMed ID: 22085793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated serum insulin-like growth factor (IGF-1) and IGF binding protein-3 levels in patients with systemic sclerosis: possible role in development of fibrosis.
    Hamaguchi Y; Fujimoto M; Matsushita T; Hasegawa M; Takehara K; Sato S
    J Rheumatol; 2008 Dec; 35(12):2363-71. PubMed ID: 19004037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating galectin-1 concentrations in systemic sclerosis: potential contribution to digital vasculopathy.
    Yanaba K; Asano Y; Akamata K; Noda S; Aozasa N; Taniguchi T; Takahashi T; Toyama T; Ichimura Y; Sumida H; Kuwano Y; Miyazaki M; Sato S
    Int J Rheum Dis; 2016 Jun; 19(6):622-7. PubMed ID: 24517166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum vaspin levels: A possible correlation with digital ulcers in patients with systemic sclerosis.
    Miura S; Asano Y; Saigusa R; Yamashita T; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Tamaki Z; Tada Y; Sugaya M; Sato S; Kadono T
    J Dermatol; 2015 May; 42(5):528-31. PubMed ID: 25708680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum apelin levels: clinical association with vascular involvements in patients with systemic sclerosis.
    Aozasa N; Asano Y; Akamata K; Noda S; Masui Y; Yamada D; Tamaki Z; Tada Y; Sugaya M; Kadono T; Sato S
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):37-42. PubMed ID: 22112232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A possible contribution of elevated serum clusterin levels to the inhibition of digital ulcers and pulmonary arterial hypertension in systemic sclerosis.
    Yanaba K; Asano Y; Tada Y; Sugaya M; Kadono T; Sato S
    Arch Dermatol Res; 2012 Aug; 304(6):459-63. PubMed ID: 22350181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum concentrations of triggering receptor expressed on myeloid cells-1 in diffuse cutaneous systemic sclerosis: association with severity of pulmonary fibrosis.
    Tomita H; Ogawa F; Hara T; Yanaba K; Iwata Y; Muroi E; Yoshizaki A; Komura K; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
    J Rheumatol; 2010 Apr; 37(4):787-91. PubMed ID: 20156945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of vascular disease biomarkers for digital ulcers in systemic sclerosis patients.
    Silva I; Teixeira A; Oliveira J; Almeida I; Almeida R; Vasconcelos C
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S127-30. PubMed ID: 26242908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum level of circulating syndecan-1: A possible association with proliferative vasculopathy in systemic sclerosis.
    Wu CY; Asano Y; Taniguchi T; Sato S; Yu HS
    J Dermatol; 2016 Jan; 43(1):63-6. PubMed ID: 26076711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digital ulcers score: a scoring system to assess digital ulcers in patients suffering from systemic sclerosis.
    Ahrens HC; Siegert E; Tomsitz D; Mattat K; March C; Worm M; Riemekasten G
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):142-147. PubMed ID: 27749240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of serum levels of secretory leukocyte protease inhibitor in patients with systemic sclerosis.
    Aozasa N; Asano Y; Akamata K; Noda S; Masui Y; Tamaki Z; Tada Y; Sugaya M; Kadono T; Sato S
    Mod Rheumatol; 2012 Aug; 22(4):576-83. PubMed ID: 22075605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of circulating platelet-activating factor acetylhydrolase levels in systemic sclerosis.
    Yanaba K; Asano Y; Tada Y; Sugaya M; Kadono T; Sato S
    Arch Dermatol Res; 2012 Apr; 304(3):203-8. PubMed ID: 22139405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of galectin-3: possible association with fibrosis, aberrant angiogenesis, and immune activation in patients with systemic sclerosis.
    Taniguchi T; Asano Y; Akamata K; Noda S; Masui Y; Yamada D; Takahashi T; Ichimura Y; Toyama T; Tamaki Z; Tada Y; Sugaya M; Kadono T; Sato S
    J Rheumatol; 2012 Mar; 39(3):539-44. PubMed ID: 22247367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum resistin levels: a possible correlation with pulmonary vascular involvement in patients with systemic sclerosis.
    Masui Y; Asano Y; Akamata K; Aozasa N; Noda S; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Yanaba K; Tada Y; Sugaya M; Sato S; Kadono T
    Rheumatol Int; 2014 Aug; 34(8):1165-70. PubMed ID: 24141536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible association of decreased serum CXCL14 levels with digital ulcers in patients with systemic sclerosis.
    Fukui Y; Miyagawa T; Hirabayashi M; Yamashita T; Saigusa R; Miura S; Nakamura K; Yoshizaki A; Sato S; Asano Y
    J Dermatol; 2019 Jul; 46(7):584-589. PubMed ID: 31087594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.